Ionis’ drug, called sapablursen, is currently being tested in a Phase 2 trial in people with polycythemia vera.
Ionis Pharmaceuticals (IONS) and Ono Pharmaceutical announced that the two companies have entered into a license agreement in which Ono obtains ...
Under the MoU, Vietravel has secured its position as Sun World's primary distribution partner, both at home and abroad.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback